Title for MeetingAbstracts
Alphabetical listing of titles
Antiretroviral treatments and HIV-positive adults' sexual practice.
Antiretroviral uptake in Australia: the effects of gender, medical advice and beliefs about efficacy and toxicity.
Antiretroviral usage in HIV-positive patients with CD4 counts < or = 200 enrolled in the rifabutin MAC prophylaxis treatment IND.
Antiretroviral usage patterns before and after instituting national treatment guidelines.
Antiretroviral usage trends: data from the national HIV telephone consultation service.
Antiretroviral use and adherence in a cohort of 696 HIV+ pregnant women.
Antiretroviral Use and Adherence Predicted by Active Illicit Drug Use.
Antiretroviral use and other care markers in a cohort of women and men followed by the Seattle spectrum of HIV-related diseases study.
ANTIRETROVIRAL USE AND REASONS FOR STOPPING AMONGST THOSE ON FIRST-LINE HAART REGIMENS.
Antiretroviral use in Malawi: experience with the government sponsored antiretroviral program.
Antiretroviral use in pregnancy in PACTG 316: a phase III randomized, blinded study of single-dose intrapartum/neonatal nevirapine to reduce mother to infant HIV transmission.
Antiretroviral use, side effects and adherence among HIV-infected persons in medical care in the U.S.
Antiretroviral-associated lipodystrophy syndrome in HIV-infected children.
Antiretrovirals (ARVs) in India-a challenge with two edges.
Antiretrovirals can restore anti-mycobacterial T-cell responses and control fatal tuberculosis-like disease in SIV/mycobacterium bovis BCG-coinfected monkeys.
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV - a Cochrane systematic review of current evidence.
Antiretrovirals--where are we and where are we going?
Antiretrovirals: most effective strategies to reduce prices.
Antiretrovirus activity and intracellular metabolism of 2',3' -didehydro-2',3' -dideoxythymidine (D4T).
Antisaccadic eye movement abnormalities in asymptomatic HIV seropositive individuals.
Antisense expression cloning of HIV host factor genes.
Antisense oligodeoxynucleotide inhibits HIV-1 second receptor: chemokine CC-CKR5 in macrophage-tropic COS cell line. Eleventh International Conference on Antiviral Research.
Antisense oligodeoxynucleotides phosphorothioate targeted to the vpr gene inhibit HIV-1 replication in primary human macrophages.
Antisense RNA inhibition of endogenous gene expression in Toxoplasma gondii.
Antiserum against papilloma-virus antigen reacts with intranuclear particles in keratinocytes of oral hairy leukoplakia, an AIDS-associated lesion.
Antisocial personality disorder and HIV behavior risk in drug users.
Antisperm antibodies as a risk factor for sexually transmitted HIV infection.
Antistaphylococcal Activity of Dalbavancin Compared to Those of Six Other Agents.
Antistaphylococcal Activity of DX-619 (Including against a VRSA Strain) Compared to Eleven Other Agents.
Antistaphylococcal Activity of RBx 7644, a New Oxazolidinone, Compared to Four Other Agents.